Total Funding
74
9
Total FundingSeries D raised
Growth Score 74 in past quarter
-1 pts
Heat Score 9 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
758905
Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.
Acquired by 

LDC Beteiligungen UG (Lead Discovery Center)
Dinko Valerio: Supervisory BoardsPast Role: Aescap Venture, Co-Founder and Managing Partner
About the Company
Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.


